A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein–Barr virus DNA as a biomarker of efficacy

Author: Ma Brigette   Hui Edwin   King Ann   To K.   Mo Frankie   Leung Sing   Kam Michael   Lo Y.   Zee Benny   Mok Tony   Ahuja Anil   Chan Anthony  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.62, Iss.1, 2008-06, pp. : 59-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next